Extended Recognition of the Histone H3 Tail by Histone Demethylase KDM5A

被引:18
作者
Petronikolou, Nektaria [1 ]
Longbotham, James E. [1 ]
Fujimori, Danica Galonic [1 ,2 ]
机构
[1] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA
[2] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA
基金
美国国家卫生研究院;
关键词
INHIBITOR; POTENT;
D O I
10.1021/acs.biochem.9b01036
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human lysine demethylase KDM5A is a chromatin-modifying enzyme associated with transcriptional regulation, because of its ability to catalyze removal of methyl groups from methylated lysine 4 of histone H3 (H3K4me3). Amplification of KDM5A is observed in many cancers, including breast cancer, prostate cancer, hepatocellular carcinoma, lung cancer, and gastric cancer. In this study, we employed alanine scanning mutagenesis to investigate substrate recognition of KDM5A and identify the H3 tail residues necessary for KDM5A-catalyzed demethylation. Our data show that the H3Q5 residue is critical for substrate recognition by KDM5A. Our data also reveal that the protein-protein interactions between KDM5A and the histone H3 tail extend beyond the amino acids proximal to the substrate mark. Specifically, demethylation activity assays show that deletion or mutation of residues at positions 14-18 on the H3 tail results in an 8-fold increase in the K-M(app), compared to wild-type 18mer peptide, suggesting that this distal epitope is important in histone engagement. Finally, we demonstrate that post-translational modifications on this distal epitope can modulate KDM5A-dependent demethylation. Our findings provide insights into H3K4-specific recognition by KDM5A, as well as how chromatin context can regulate KDM5A activity and H3K4 methylation status.
引用
收藏
页码:647 / 651
页数:5
相关论文
共 20 条
  • [1] The molecular hallmarks of epigenetic control
    Allis, C. David
    Jenuwein, Thomas
    [J]. NATURE REVIEWS GENETICS, 2016, 17 (08) : 487 - 500
  • [2] 8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase Inhibitors
    Bavetsias, Vassilios
    Lanigan, Rachel M.
    Ruda, Gian Filippo
    Atrash, Butrus
    McLaughlin, Mark G.
    Tumber, Anthony
    Mok, N. Yi
    Le Bihan, Yann-Vai
    Dempster, Sally
    Boxall, Katherine J.
    Jeganathan, Fiona
    Hatch, Stephanie B.
    Savitsky, Pavel
    Velupillai, Srikannathasan
    Krojer, Tobias
    England, Katherine S.
    Sejberg, Jimmy
    Thai, Ching
    Donovan, Adam
    Pal, Akos
    Scozzafava, Giuseppe
    Bennett, James M.
    Kawamura, Akane
    Johansson, Catrine
    Szykowska, Aleksandra
    Gileadi, Carina
    Burgess-Brown, Nicola A.
    von Delft, Frank
    Oppermann, Udo
    Walters, Zoe
    Shipley, Janet
    Raynaud, Florence I.
    Westaway, Susan M.
    Prinjha, Rab K.
    Fedorov, Oleg
    Burke, Rosemary
    Schofield, Christopher J.
    Westwood, Isaac M.
    Bountra, Chas
    Mueller, Susanne
    van Montfort, Rob L. M.
    Brennan, Paul E.
    Blagg, Julian
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (04) : 1388 - 1409
  • [3] RBP2 belongs to a family of demethylases, specific for tri- and dimethylated lysine 4 on histone 3
    Christensen, Jesper
    Agger, Karl
    Cloos, Paul A. C.
    Pasini, Diego
    Rose, Simon
    Sennels, Lau
    Rappsilber, Juri
    Hansen, Klaus H.
    Salcini, Anna Elisabetta
    Helin, Kristian
    [J]. CELL, 2007, 128 (06) : 1063 - 1076
  • [4] Expression patterns and post-translational modifications associated with mammalian histone H3 variants
    Hake, SB
    Garcia, BA
    Duncan, EM
    Kauer, M
    Dellaire, G
    Shabanowitz, J
    Bazett-Jones, DP
    Allis, CD
    Hunt, DF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (01) : 559 - 568
  • [5] Structure-Based Engineering of Irreversible Inhibitors against Histone Lysine Demethylase KDM5A
    Horton, John R.
    Woodcock, Clayton B.
    Chen, Qin
    Liu, Xu
    Zhang, Xing
    Shanks, John
    Rai, Ganesha
    Mott, Bryan T.
    Jansen, Daniel J.
    Kales, Stephen C.
    Henderson, Mark J.
    Cyr, Matthew
    Pohida, Katherine
    Hu, Xin
    Shah, Pranav
    Xu, Xin
    Jadhav, Ajit
    Maloney, David J.
    Hall, Matthew D.
    Simeonov, Anton
    Fu, Haian
    Vertino, Paula M.
    Cheng, Xiaodong
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (23) : 10588 - 10601
  • [6] Structural Basis for KDM5A Histone Lysine Demethylase Inhibition by Diverse Compounds
    Horton, John R.
    Liu, Xu
    Gale, Molly
    Wu, Lizhen
    Shanks, John R.
    Zhang, Xing
    Webber, Philip J.
    Bell, Joshua S. K.
    Kales, Stephen C.
    Mott, Bryan T.
    Rai, Ganesha
    Jansen, Daniel J.
    Henderson, Mark J.
    Urban, Daniel J.
    Hall, Matthew D.
    Simeonov, Anton
    Maloney, David J.
    Johns, Margaret A.
    Fu, Haian
    Jadhav, Ajit
    Vertino, Paula M.
    Yan, Qin
    Cheng, Xiaodong
    [J]. CELL CHEMICAL BIOLOGY, 2016, 23 (07): : 769 - 781
  • [7] Characterization of a Linked Jumonji Domain of the KDM5/JARID1 Family of Histone H3 Lysine 4 Demethylases
    Horton, John R.
    Engstrom, Amanda
    Zoeller, Elizabeth L.
    Liu, Xu
    Shanks, John R.
    Zhang, Xing
    Johns, Margaret A.
    Vertino, Paula M.
    Fu, Haian
    Cheng, Xiaodong
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (06) : 2631 - 2646
  • [8] Johansson C, 2016, NAT CHEM BIOL, V12, P539, DOI [10.1038/nchembio.2087, 10.1038/NCHEMBIO.2087]
  • [9] The retinoblastoma binding protein RBP2 is an H3K4 demethylase
    Klose, Robert J.
    Yan, Qin
    Tothova, Zuzana
    Yamane, Kenichi
    Erdjument-Bromage, Hediye
    Tempst, Paul
    Gilliland, D. Gary
    Zhang, Yi
    Kaelin, William G., Jr.
    [J]. CELL, 2007, 128 (05) : 889 - 900
  • [10] Chromatin modifications and their function
    Kouzarides, Tony
    [J]. CELL, 2007, 128 (04) : 693 - 705